Infertility is defined as not being able to become pregnant despite having frequent, unprotected intercourse for at least one year. The cause of infertility can affect one or both partners.
Causes of female infertility include ovulation disorders, uterine or cervical abnormalities, Fallopian tube damage or blockage, endometriosis, early menopause and pelvic adhesions resulting from prior infection or surgery. It can also be a result of cancer and its treatment, metabolic and autoimmune diseases and genetic abnormalities.
Causes of male infertility include abnormal sperm production or function, problems with delivery of sperm, toxins, medications, illicit drug use, cancer and cancer treatment.
Dr. Phil Boyle
Dr. Phil Boyle, MB BCh NUI, MICGP, MRCGP, CFCP is the Director of the NaPro Fertility Care Clinic in Dublin, Ireland, and President of the International Institute for Restorative Reproductive Medicine. He is an active member of the American Academy Fertility Care Professionals (AAFCP), a certified Fertility Care Physician (CFCP), and an active member of the Irish Fertility Society.
What he was surprised to see was how many of his infertile patients with autoimmune diseases became pregnant while taking LDN.
As a family physician by training, Dr. Boyle had experience treating patients with autoimmune disease such as rheumatoid arthritis (RA) and multiple sclerosis (MS) with low dose naltrexone (LDN), as an “off-label” medication. He knew that modulating the immune system by stimulating endogenous endorphin production resulted in an improvement in symptoms. What he was surprised to see was how many of his infertile patients with autoimmune diseases became pregnant while taking LDN. He surmised that their infertility must be caused by an endorphin deficiency, and that LDN - well known to stimulate endorphin production - is responsible for restoration of fertility.
What are endorphins, how do they affect health, and what role does LDN play? Read here.
Based on LDN’s mechanism of action, Dr. Boyle has successfully treated many infertile patients with LDN due its ability to stimulate endorphin production in those patients who have shown symptoms of endorphin deficiency.
Based on LDN’s mechanism of action, Dr. Boyle has successfully treated many infertile patients with LDN due its ability to stimulate endorphin production in those patients who have shown symptoms of endorphin deficiency. He has also successfully prescribed LDN to women with endometriosis and has observed a lower incidence of miscarriage and better, healthier pregnancies for women who continue using it during pregnancy. Using LDN during pregnancy is safe and in fact, he has found that women who continue taking LDN until 37 weeks of pregnancy have better outcomes.
Read LDNscience’s interview with Dr. Philip Boyle.
Dipyridamole Eye Drops
Cureiosity®